BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38698201)

  • 1. Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis.
    Makinoya M; Miyatani K; Matsumi Y; Sakano Y; Shimizu S; Shishido Y; Hanaki T; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Nakayama Y; Osaki M; Okada F; Fujiwara Y
    Sci Rep; 2024 May; 14(1):10075. PubMed ID: 38698201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
    Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
    Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer.
    Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7.
    Zhu M; Zhang N; He S; Lu X
    Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
    Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
    Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA PLEC acts as a sponge of microRNA-198 to promote gastric carcinoma cell resistance to paclitaxel and tumorigenesis.
    Zhou N; Wang W; Xu C; Yu W
    Pathol Res Pract; 2021 Aug; 224():153487. PubMed ID: 34225215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
    Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
    Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
    Cancer Lett; 2019 Sep; 459():122-134. PubMed ID: 31173853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal paclitaxel induces regression of peritoneal metastasis partly by destruction of peripheral microvessels.
    Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Watanabe T
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):605-12. PubMed ID: 24464356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
    Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
    Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
    Liu YY; Zhang LY; Du WZ
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
    Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
    Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
    Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
    Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
    Takashima A; Shitara K; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Fujii H; Muro K; Esaki T; Choda Y; Takano T; Chin K; Sato A; Goto M; Fukushima N; Hara T; Machida N; Ohta M; Boku N; Shimura M; Morita S; Koizumi W
    Gastric Cancer; 2019 Jan; 22(1):155-163. PubMed ID: 29855738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
    Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
    Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis.
    Ji FJ; Wu YY; An Z; Liu XS; Jiang JN; Chen FF; Fang XD
    Sci Rep; 2017 Nov; 7(1):15488. PubMed ID: 29138420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.